Mirabegron as a treatment for overactive bladder symptoms in men (MIRACLE study): Efficacy and safety results from a multicenter, randomized, double-blind, placebo-controlled, parallel comparison phase IV study

Dong Gil Shin; Hyeon Woo Kim; Sang Jin Yoon; Sang Hoon Song; Young Ho Kim; Young Goo Lee; Kwan Joong Joo; Jae Hyun Bae; Taek Won Kang; Seong Jin Jeong; Seung Hyo Woo; Eun Sang Yoo; Hwancheol Son; Kyo Chul Koo; Soo Woong Kim

doi:10.1002/nau.23852

Mirabegron as a treatment for overactive bladder symptoms in men (MIRACLE study): Efficacy and safety results from a multicenter, randomized, double-blind, placebo-controlled, parallel comparison phase IV study

Neurourology and Urodynamics ◽

10.1002/nau.23852 ◽

2018 ◽

Vol 38 (1) ◽

pp. 295-304 ◽

Cited By ~ 7

Author(s):

Dong Gil Shin ◽

Hyeon Woo Kim ◽

Sang Jin Yoon ◽

Sang Hoon Song ◽

Young Ho Kim ◽

...

Keyword(s):

Overactive Bladder ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Overactive Bladder Symptoms ◽

Bladder Symptoms ◽

Phase Iv

Download Full-text

Faculty Opinions recommendation of OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718006591.793478312 ◽

2013 ◽

Author(s):

Francisco Cruz

Keyword(s):

Quality Of Life ◽

Urinary Incontinence ◽

Overactive Bladder ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Overactive Bladder Symptoms ◽

Bladder Symptoms

Download Full-text

Faculty Opinions recommendation of OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718006591.793482693 ◽

2013 ◽

Author(s):

Hashim Hashim ◽

Riyad Almousa

Keyword(s):

Quality Of Life ◽

Urinary Incontinence ◽

Overactive Bladder ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Overactive Bladder Symptoms ◽

Bladder Symptoms

Download Full-text

Effects of solifenacin on overactive bladder symptoms, symptom bother and other patient-reported outcomes: results from VIBRANT - a double-blind, placebo-controlled trial

International Journal of Clinical Practice ◽

10.1111/j.1742-1241.2009.02209.x ◽

2009 ◽

Vol 63 (12) ◽

pp. 1702-1714 ◽

Cited By ~ 38

Author(s):

M. D. Vardy ◽

H. D. Mitcheson ◽

T.-A. Samuels ◽

J. D. Wegenke ◽

S. Forero-Schwanhaeuser ◽

...

Keyword(s):

Overactive Bladder ◽

Patient Reported Outcomes ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Overactive Bladder Symptoms ◽

Symptom Bother ◽

Patient Reported ◽

Bladder Symptoms

Download Full-text

A Phase 2, Randomized, Double-Blind, Efficacy and Safety Study of Oxybutynin Vaginal Ring for Alleviation of Overactive Bladder Symptoms in Women

The Journal of Urology ◽

10.1016/j.juro.2013.11.019 ◽

2014 ◽

Vol 191 (4) ◽

pp. 1014-1021 ◽

Cited By ~ 12

Author(s):

Marc Gittelman ◽

Herman Weiss ◽

Larry Seidman

Keyword(s):

Overactive Bladder ◽

Vaginal Ring ◽

Phase 2 ◽

Efficacy And Safety ◽

Safety Study ◽

Double Blind ◽

Overactive Bladder Symptoms ◽

Bladder Symptoms

Download Full-text

Faculty of 1000 evaluation for A Phase 2, Randomized, Double-Blind, Efficacy and Safety Study of Oxybutynin Vaginal Ring for Alleviation of Overactive Bladder Symptoms in Women.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.718176906.793487117 ◽

2013 ◽

Author(s):

Altaf Mangera

Keyword(s):

Overactive Bladder ◽

Vaginal Ring ◽

Phase 2 ◽

Efficacy And Safety ◽

Safety Study ◽

Double Blind ◽

Overactive Bladder Symptoms ◽

Bladder Symptoms

Download Full-text

OnabotulinumtoxinA 100U Significantly Improves All Idiopathic Overactive Bladder Symptoms and Quality of Life in Patients with Overactive Bladder and Urinary Incontinence: A Randomised, Double-Blind, Placebo-Controlled Trial

Yearbook of Urology ◽

10.1016/j.yuro.2014.03.010 ◽

2014 ◽

Vol 2014 ◽

pp. 65-67

Author(s):

E.S. Rovner

Keyword(s):

Quality Of Life ◽

Urinary Incontinence ◽

Overactive Bladder ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Overactive Bladder Symptoms ◽

Bladder Symptoms

Download Full-text

Faculty Opinions recommendation of OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718006591.793477069 ◽

2013 ◽

Author(s):

Howard Goldman

Keyword(s):

Quality Of Life ◽

Urinary Incontinence ◽

Overactive Bladder ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Overactive Bladder Symptoms ◽

Bladder Symptoms

Download Full-text

OnabotulinumtoxinA 100 U Significantly Improves All Idiopathic Overactive Bladder Symptoms and Quality of Life in Patients with Overactive Bladder and Urinary Incontinence: A Randomised, Double-Blind, Placebo-Controlled Trial

European Urology ◽

10.1016/j.eururo.2013.04.001 ◽

2013 ◽

Vol 64 (2) ◽

pp. 249-256 ◽

Cited By ~ 216

Author(s):

Christopher Chapple ◽

Karl-Dietrich Sievert ◽

Scott MacDiarmid ◽

Vik Khullar ◽

Piotr Radziszewski ◽

...

Keyword(s):

Quality Of Life ◽

Urinary Incontinence ◽

Overactive Bladder ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Overactive Bladder Symptoms ◽

Bladder Symptoms

Download Full-text

Faculty Opinions recommendation of A randomized double-blind placebo-controlled multicentre study to explore the efficacy and safety of tamsulosin and tolterodine in women with overactive bladder syndrome.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1090972.544337 ◽

2007 ◽

Author(s):

Rodolfo Testa

Keyword(s):

Overactive Bladder ◽

Multicentre Study ◽

Overactive Bladder Syndrome ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Mirabegron for treatment of overactive bladder symptoms in patients with Parkinson's disease: A double‐blind, randomized placebo‐controlled trial (Parkinson's Disease Overactive bladder Mirabegron, PaDoMi Study)

Neurourology and Urodynamics ◽

10.1002/nau.24552 ◽

2021 ◽

Author(s):

Sung Yong Cho ◽

Seong Jin Jeong ◽

Sangchul Lee ◽

Janghwan Kim ◽

Seong Ho Lee ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Overactive Bladder ◽

Controlled Trial ◽

Double Blind ◽

Overactive Bladder Symptoms ◽

Bladder Symptoms

Download Full-text